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Available online 2 March 2014Neuroblastoma is the most common extracranial pediatric solid tumor with poor prognosis in
children with disseminated stage of disease. A number of studies show that molecules largely
distributed in commonly consumed fruits and vegetablesmayhave anti-tumor activity. In this study
we evaluate the effect of Citrus bergamia (bergamot) juice (BJ) in vitro and in a spontaneous
metastatic neuroblastoma SCID mouse model. Qualitative and quantitative characterizations of BJ
flavonoid fractions were performed by RP-HPLC/PDA/MS. We show that BJ significantly affects
SK-N-SH and LAN-1 cell proliferation in vitro, but fails to reduce primary tumor weight in vivo.
Moreover, BJ reduced cell adhesiveness and invasion of LAN-1 and SK-N-SH cells in vitro and the
number of pulmonary metastases under consideration of the number of tumor cells in the blood in
mice inoculatedwith LAN-1 cells in vivo. These effectswithout any apparent sign of systemic toxicity
confirm the potential clinical interest of BJ and lay the basis for further investigation in cancer.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Keywords:
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Neuroblastoma (NB) is themost common tumor in children
less than one year of age worldwide. Each year, approximately
1500 cases occur in Europe and 700 in the USA and Canada,
accounting for about 28% of all cancers diagnosed in European
and USA infants [1]. NB is a malignant embryonic tumor of the
neural crest cells and therefore can develop anywhere along
the strands of the sympathetic nervous system [2]. Hema-
togenous metastasis is present in about half of NB patients
and is responsible for many NB deaths. Although aggressive
and intensive multimodality therapies (surgery, cytotoxic
chemotherapy, radio-metabolic treatment) have produced
some improvements in the overall cure rate of NB patients,
the prognosis of patients with metastatic NB remains poor.al Medicine, Institute
y Hospital Hamburg-
y. Tel.: +49 40 7410
.
. This is anopenaccess article unThus, novel therapeutic strategies to ameliorate the prog-
nosis of NB patients are required.
Plant kingdom has always been an attractive source of
novel anticancer drugs resulting in the fact that about 50% of
anticancer drugs are natural or semisynthetic products [3].
Epidemiologic studies provided evidence that Citrus con-
sumption is associated with a reduced all-cancer incidence,
although significant results were obtained only for prostate
and pancreatic cancers [4]. In contrast, some studies did not
find an association between Citrus fruit intake and cancer
prevention [5,6]. However, several in vivo studies suggest
that Citrus juices have a potential in cancer prevention. Thus,
it has been documented that mandarin juice may reduce
both chemically-induced rat colon carcinogenesis [7] and
lung cancer formation [8]. Moreover, orange juice may
decrease both chemically-induced mammary tumor burden
and azoxymethane-induced colon cancer in rats [9,10].
Further, grapefruit juice shows a suppressive effect on in
vivo induced colon carcinogenesis [11].
Citrus bergamia Risso et Poiteau (bergamot) is a small tree
belonging to the family Rutaceae. 90% of bergamot worldwideder theCCBY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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(Italy), where the microclimatic characteristics are particularly
suitable for its cultivation. Bergamot fruit is usedmostly for the
extraction of its essential oil from the peel, a basic component
of fragrances. Bergamot juice (BJ), which is obtained from the
endocarp after essential oil extraction, is considered just as a
secondary and discarded product with disposal costs. Over the
past few years BJ attracted large attention as a result of its
remarkable content of flavonoids, known for their beneficial
effects.
Flavonoids are polyphenolic compounds present in vegeta-
bles, especially in the genus Citrus, characterized by a common
benzo-γ-pyrone structure. More than 8000 compounds of
flavonoid structure have been described. The large number
of molecules arises from various combinations of multiple
hydroxyl and methoxyl groups substituting the basic flavonoid
skeleton. Numerous pre-clinical and epidemiological studies
point to a possible protective effect of flavonoids against
cardiovascular and malignant diseases, linked to their abilities
to inhibit enzymes involved in cell activation [12].
Recently, we have shown that BJ reduces growth rates of
different cancer cell lines, by mechanisms that in SH-SY5Y
neuroblastoma cells are linked to an early impairment in
cell adhesive and migratory processes [13]. However, until
now the anticancer properties of BJ in vivo have not been
investigated. On these bases, the present studywas designed to
evaluate the effect of BJ both in vitro and in an experimental
model of spontaneous metastasis formation of human NB cells
xenografted into immunodeficient mice.
2. Materials and methods
2.1. Plant material
Bergamot fruits were collected from C. bergamia cultiva-
tion located in Bovalino (Reggio Calabria, Italy). The fruits
were hand-squeezed and small aliquots of the juice (BJ) were
stored at−20 °C. BJ was defrosted and filtered (0.22 μmpore
size) before use. For cell culture experiments, the pH of BJ
was adjusted to 7.4 and subsequently diluted in culture
media until the desired concentrations are achieved.
2.2. Quali-quantitative evaluation of ﬂavonoids in
bergamot juice
The juice was analyzed without any pre-treatment: the
juice was centrifuged and then filtered on Acrodisc filter
0.22 μm. The sample was analyzed in triplicate by RP-HPLC.
Since the pH of the BJ is roughly 3.5–3.8, all the mobile phases
have been adjusted to the appropriate pH value (pH 3) with
formic acid in order to suppress the ionization of the phenolic
groups [14].
LC analyses were carried out using a Shimadzu Prominence
LC-20A system (Shimadzu, Milan, Italy), including a CBM-20A
controller, two LC-20 AD dual-plunger parallel-flow pumps,
a DGU-20A3 on-line degasser, and a CTO-20A column oven.
Data were acquired and processed by LCsolution Version
1.21 SP1 software (Shimadzu). An SPD-M20A UV detector
and an LCMS-2020, through ESI interface (Shimadzu), were
employed for quantification and characterization of bioactivemolecules, respectively. MS data acquisition was performed by
the LCMSsolution Ver. 3.30 software (Shimadzu).
LC analyses were carried out on an Ascentis Express C18,
150 × 4.6 mm I.D. with a particle size of 2.7 μm (Supelco,
Bellefonte, PA). The injection volumewas 2 μl: mobile phase
consisted of water/formic acid (99.9:0.1, v/v; solvent A) and
acetonitrile/formic acid (99.9:0.1, v/v; solvent B). The step-
wise gradient profile was as follows: 0 min, 5% B, 40 min, 25%
B, 60 min, 100% B, 70 min, 100% B, 73 min, 5%, and 80 min
5% B. Flow-rate was 0.7 ml/min. Data were acquired using a
photodiode array detector in the range 190–400 nm and the
chromatograms were extracted at 283 nm and 325 nm.
Time constant was 0.64 s and sample frequency 1.5625 Hz.
Data acquisition was performed by Shimadzu LCsolution
software ver 3.3.
MS acquisition was performed using ESI in negative mode.
ESI conditions:mass spectral range,m/z 100–700; interval, 0.5 s;
scan speed, 938 amu/s; nebulizing gas (N2) flow, 1.5 l/min;
ESI temperature, 350 °C; heat block, 300 °C; DL (desolvation
line) temperature, 300 °C; DL, voltage, −34 V; probe voltage,
+4.5 kV; Qarray voltage, 1.0 V and detection gain, 1.05 kV.
To quantify the flavonoid content in the BJ, calibration
curves have been constructed by using each single standard.
Five different concentrations of each component in the range
between 100 and 0.2 mg/l (stock solution of 1000 mg/l in
methanol) were analyzed for five consecutive times by HPLC
under the same chromatographic conditions optimized for
the sample. Limit of detection (LOD) and limit of quantifica-
tion (LOQ) values were also calculated as reported [14].2.3. Cell lines, proliferation assay and cytotoxicity study
SK-N-SH and LAN-1 human NB cell lines were cultured
as described for other NB cell lines [15] at 37 °C in a humidified
atmosphere containing 5% CO2 in RPMI 1640 supplemented
with 10% (vol/vol) heat inactivated fetal bovine serum (FBS),
1 mMsodiumpyruvate, 2 mML-glutamine, 100 IU/ml penicillin
and 100 μg/ml streptomycin. At confluence, cells were routinely
harvested using 0.05% trypsin–0.02% EDTA and replaced in
75 cm2 tissue culture flasks. All chemicals were from Gibco
(Paisley, Scotland and Milan, Italy).
Cell proliferation was quantified by the MTT assay [16]
with modifications. Cells were plated into 96-well plates
at a density of 15 × 103 cells/ml (LAN-1) or 6 × 103 cells/ml
(SK-N-SH) and cultured for 24 h before administration of
growing percentage of BJ (from 1% to 10%). Each concentra-
tion was eightfold tested and at least four independent
experiments were carried out. The control cells received only
fresh medium. After incubation for 24, 48 and 72 h, the plates
were centrifuged to collect the floating cells in the media,
and the supernatants in each well were replaced with 100 μl
fresh medium without phenol red containing 0.5 mg/ml of
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazoliumbromide
(MTT; Sigma-Aldrich; Milan, Italy). The plates were returned
in the incubator for 4 h and gently shaken occasionally. Then,
the medium was removed and 100 μl of ethanol/dimethyl
sulfoxide (DMSO) 1:1 lysis buffer was added to solubilize the
formed formazan crystals (MTT metabolic product) that were
spectrophotometrically quantified with a microplate spectro-
photometer (Bio-Rad Laboratories, Milan, Italy). Absorbance of
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cells was expressed as a percentage relative to the control.
Cell growthwas also detected by the cell count assay. Briefly,
SK-N-SH and LAN-1 cells were seeded onto 6-well plates
(1 × 105 cells/well for the SK-N-SH and 3 × 105 cells/well
for the LAN-1 cells) and the next day treated with the BJ
ranging from 1% to 10%. Then, cells were harvested, centrifuged
and resuspended in a known amount of culture medium
containing the trypan blue dye for distinguishing live cells from
death. Aliquots of cell suspensions were put in a Neubauer
hemocytometric chamber and cells were count by a common
optical microscope.
Possible cytotoxic effects of BJwas assessed by a trypan blue
dye (0.4% v/v) exclusion test and cell deathwas reported as the
percentage of stained (non-viable) vs total cells counted [17].
All the tests were carried out in eightplicate (MTT) or in
triplicate (cell count and trypan blue) and repeated three
times.2.4. Laminar ﬂow assay
Laminar flowwas produced in IBIDI microslides VI (IBIDI
GmbH, München, Germany; ibiTreat-pretreatment; width:
3.8 mm, height: 0.4 mm, volume of each capillary: 30 μl)
connected to a syringe pump (model 100 Series; KD Scientific,
Holliston, MA, USA) and cell movement was observed with
an inverted microscope (Zeiss, Axiovert 200). SK-N-SH
and LAN-1 cells were treated with 5% BJ for 24 h and then
detached, span down and resuspended in cell culture medium
(1 × 105 cells/ml). Microslides were coated with recombinant
human (rh) E- (5 μg/ml) or P-(50 μg/ml) selectin Fc-chimeras
(R&D Systems GmbH, Wiesbaden, Germany) diluted in PBS
[18]. A control capillary was incubated with the conjugated
Fc-fragment (rh IgG1-Fc; R&D Systems) to serve as the negative
control. Capillaries and hoses were rinsed with cell culture
medium containing 10% FBS to block nonspecific binding
before to be connected to the cell suspensions. Physiological
shear stress [19] was produced with a syringe pump initially
set to 0.5 dyn/cm for 3 min and subsequently raised to 1.0
and 1.5 dyn/cm for 3 min each. Rolling or adhesive cells
were recorded and analyzed using a specially designed analyz-
ing program (CapImage 8.5, Dr. Heinrich Zeintl, Heidelberg,
Germany). Two independent experiments were conducted and
analyzed.2.5. Invasion assay
Cell invasion experimentswere performedusing theMatrigel
Invasion Chambers constituted by 24 well plates equipped
with 8 μm pore size polycarbonate filters overcoated with
Matrigel (Corning Inc., New York, USA). LAN-1 (1 × 105) or
SK-N-SH (4 × 104) cells were seeded in RPMI with 2% FBS in
the upper compartment of each chamber. Medium with 10%
serum was added to the lower compartment. BJ (ranging
from 0.25% to 5%) was added to the upper compartment and
after 24 h the cells which invaded to the lower side of the
Matrigel coated filter were collected and counted in Neubauer
hemocytometric chamber [20]. The test was repeated three
times.2.6. Wound healing assay
LAN-1 or SK-N-SH cells were cultured in 6 well plates
in normal culture conditions until confluence. Thereafter,
monolayer of NB cells was scratched using a thin sterile pipette
tip, and culture dishes were washed with RPMI. Then, cultures
were treated or not with BJ 1% for 12 h and the wounds were
photographed by an inverted contrast phase microscopy. This
assay has been remade three times.
2.7. Study in experimental tumors
Forty-eight male and female severe combined immu-
nodeficient (SCID) mice, aged 9 ± 14 weeks (Charles River
Laboratories, Sulzfeld, Germany), weighing on average
25 g (SEM ± 0.5 g) at the beginning of the experiments,
were used. The research was conducted in accordance with the
internationally accepted principles for laboratory animal use and
care with stating the guidelines (Directive 2010/63/EU). The
animal tests were approved by the local animal experiment
approval committee (Behörde für Soziales, Familie, Gesundheit,
Verbraucherschutz; Amt fürGesundheit undVerbraucherschutz,
Hamburg, Germany) and assigned the project number 19/10.
SK-N-SH and LAN-1 NB cell inoculations were performed
as described [21]. Cells were harvested by trypsination and
suspended in cold culture media diluted 1:1 with Matrigel
(Becton Dickinson GmbH, Heidelberg, Germany). Forty-eight
mice were divided into two groups and inoculated with
SK-N-SH and LAN-1 cells, respectively (24 mice per cell line).
An aliquot of 200 μl (1 × 106 cells) of this suspension was
injected subcutaneously between the scapulae of each SCID
mouse.
Oneday after tumor cell inoculations, 200 μl ofmicrofiltered
C. bergamia juice was orally administered to the mice of the
BJ-treated groups, while themice of the control groups received
200 μl of sterilized water. Treatment was repeated once a day
for a total of 28 days, at the same time. Common behavior
(eating, drinking, climbing, social interactions) and signs of pain
and distress (weight loss, ruffled fur, ocular discharge, lethargy,
ataxia, labored respiration, hypothermia) were regularly re-
corded, and no signs of impairment caused by the treatment
were noticed. Twenty-nine days after cell inoculation mice
were terminally anesthetized with intraperitoneal injections of
0.1 ml/10 g body weight Rompun/Ketanest (0.8 ml Rompun
2% by Bayer, Leverkusen, Germany plus 1.2 ml Ketamin Gräub
100 mg/ml from Albrecht, Aulendorf, Germany in 8 ml 0.9%
NaCl). The blood samples were transferred in EDTAmicrotubes
and stored at 4 °C until use for DNA extraction. The primary
tumors and lungs were removed and fixed in 4% paraformal-
dehyde (PFA) in PBS.
2.8. Lung metastasis detection
The lungs were fixed en bloc and cut into 1 mm thick slices,
spread randomly over a glass slide and then embedded in 2%
agar (Agar Noble; Difco Laboratories, Detroit, MI, USA). The
solidified agar blocks were subsequently processed for routine
wax histology and serially sectioned. Every tenth section
was retained and ten sections from the middle of the block
were stained with hematoxylin–eosin. The lung metastases
were counted using a Zeiss Axioplan photomicroscope (Jena,
Fig. 1. RP-HPLC/PDA/MS chromatogram of flavonoids in bergamot juice. For
peak identification see Table 1.
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mined as described previously [22].
2.9. Analysis of tumor cells in the blood
In order to detect human tumor cells in the bloodstream,
quantification of human tumor cell DNA via Alu sequences was
carried out [23]. In brief, quantitative real-time polymerase
chain reaction (qRT-PCR) and melting curve analyses were
performed in the well of 96-well plate with the LightCycler®
480 1.5 System. For the qRT-PCR the LightCycler Fast Start DNA
MasterPLUS SYBR Green I Kit (Roche Diagnostics GmbH,
Mannheim, Germany) was used. DNA was extracted from
200 μl of the blood by QIAmp DNA Blood Mini Kit (Qiagen
GmbH, Hilden, Germany). Two microliter DNA was used as
templates for the PCR reaction and incubated in a total reaction
volume of 10 μl, containing 1× SYBR Green I Master mix
including Taq DNA polymerase, Taq PCR buffer, a dNTP mixture,
1 mmol/l MgCl2, and 10 pmol specific Alu primers. Forward Alu
primer (TGGCTCACGCCTGTAATC CCA) and reverse Alu primer
(GCC ACT ACG CCC GGC TAA TTT) were synthesized by
MWG-Biotech AG (Ebersberg, Germany). The PCR conditions
were initially 10 min 95 °C, followed by 50 cycles of 5 s 95 °C,
5 s 67 °C and 20 s 72 °C (measurement of fluorescence).Melting
curve analysis (1 s 95 °C, 1 s 65 °C and0 s 95 °C)was performed
directly after PCR run. Quantification of disseminated tumor cells
in the mouse blood was based on a standard curve using the
blood spiked with in vitro grown SK-N-SH and LAN-1 NB cells
(1 cell/ml up to 1 × 106 cells/ml).
2.10. Statistical analysis
MTT data were statistically analyzed by one-way analysis
of variance (ANOVA), followed by Tukey–Kramer multiple
comparison test (GraphPad Software for Science, San Diego,
USA). Post-mortem primary tumor weights of control and
BJ-treated groups were compared by two-tailed Student's
t-test. Numbers of pulmonary metastases and disseminated
tumor cells in the blood, respectively, were logarithmized.
Two-tailed Student's t-test was used to compare the values
of control and treated groups. Logarithmized numbers of
lung metastases were also evaluated by an analysis of
covariance (ANCOVA) with factor logarithmized numbers
of tumor cells in the blood and including interaction terms of
mouse group ∗ logarithmized numbers of tumor cells in the
blood. This non-significant interaction was omitted (back-
ward selection) and the effect estimated for the final model
was presented with P value. These statistical tests were
carried out using IBM SPSS statistics software (SPSS version
18.0 for Windows, IBM, Ehningen, Germany). P b 0.05 was
considered as a statistically significant result. All data were
visualized using GraphPad Prism 5.0.
3. Results
3.1. Flavonoid composition of bergamot juice
In this paper, the identification and quantification of the
flavonoid content in BJ were attained by means of RP-HPLC in
combination with UV and MS detectors. Identification of the
bioactive molecules was carried out by LCMS detection andcomparison with standard materials, when available. For all
molecule classes studied in this work, the validation process
provided good results for LOD and LOQ, ranging from 0.034 to
0.080 mg/l and from 0.047 to 0.113 mg/l, respectively. R2
coefficients, ranging from 0.991 to 1.000 were attained for all
the analytes, showing a good linearity for the method used.
Fig. 1 shows the RP-HPLC/UV chromatogram of flavonoids in
BJ. The flavonoid quantitative composition (mg/l ± standard
deviation) in the BJ analyzed is reported in Table 1.
3.2. Effects of bergamot juice on neuroblastoma cell proliferation
in vitro
Incubation of LAN-1 and SK-N-SH cells with growing
concentrations of BJ ranging from 0.5% to 10% for 24, 48 and
72 h reduced cell proliferation in a concentration-dependent
manner (Fig. 2). Concentrations of BJ up to 5% did not
significantly influence cell growth of LAN-1, while SK-N-SH
cells appear to be more sensitive to treatment, since BJ was
effective also at concentrations of 1% (incubation time 24 and
48 h P b 0.05 vs control; incubation time 72 h P b 0.01 vs
control) and 2.5% (P b 0.001). Moreover, 5% BJ incubation for
48 and 72 h decreased SK-N-SH cell proliferation of 80 and
90%, respectively, whereas in LAN-1 cells the growth inhibition
reached about 50%. The strongest antiproliferative effect was
obtained incubating the cells with 10% BJ for 72 h: a cell growth
reduction of 95% in SK-N-SH and of 85% in LAN-1 is achieved
under this experimental condition (P b 0.001 vs untreated
cultures; Fig. 2A). MTT data were confirmed by those of the cell
count assay (Fig. 2B).
In order to assess the cytotoxic effects eventually induced
by the BJ either SK-N-SH or LAN-1 cells were incubated with
different concentrations of BJ (from1 to 10%) for 24 h, and then
the trypan blue dye exclusion test was performed to detect
dead cells. Fig. 3 shows that BJ induced significant increase in
cell death in both cell lines only at the higher concentration
(10%; P b 0.05 vs control), suggesting to pursue the in vitro
studies with concentrations of BJ not greater than 5%.
3.3. The bergamot juice affects cell adhesion, invasion andmigration
in vitro
SK-N-SH cells showed adhesion on rh E-selectin–Fc-chimera
coated surface (5 μg/ml). As shown in Fig. 4, treatment with
5% BJ reduced adhesive SK-N-SH cells per time unit and field
of view (0.8 × 0.6 mm), especially under low shear stress of
Table 1
Values of λmax (nm), [M − H]−, concentration (mg/l ± SD) and CV% of
flavonoids in bergamot juice analyzed.
N° Compounds λmax [M − H]− mg/l CV%
1 Apigenin-6,8-di-
C-glucoside
272, 336 593 33 ± 1.8 5.52
2 Diosmetin-6,8-di-
C-glucoside
272, 348 623 29 ± 1.9 6.63
3 Eriocitrin 252, 259 595 (287)a 24 ± 0.8 3.33
4 Neoeriocitrin 285 595 78 ± 3.5 4.46
5 Poncirin 224, 285 594 21 ± 0.9 4.28
6 Naringin 227, 284 579 111 ± 5.7 5.13
7 Narirutin 224, 285 579 (271)a 17 ± 0.3 1.76
8 Neodiosmin 253, 268, 349 607 15 ± 0.4 2.66
9 Neohesperidin 218, 285 609 84 ± 2.4 2.84
10 Naringenin 224, 285 723 34 ± 1.1 3.10
11 Rhoifolin 262, 339 577 9 ± 0.6 6.41
12 Hesperetin 225, 284 753 108 ± 3.9 3.60
13 Diosmin 224, 285, 342 607 (299)a 38 ± 0.5 1.32
All 610 ± 21.5 3.52
a Between parenthesis the daughter ion value for compounds 3, 5, 10, 11,
and 12 is reported.
87M. Navarra et al. / Fitoterapia 95 (2014) 83–920.5 dyn/cm2 (control: 18.5 vsBJ: 4.5). LAN-1 cells rarely adhered
to E-selectin independent of treatmentwith BJ, so that the effect
of BJ on LAN-1 cell adhesion to E-selectin could not be evaluated.
No adhesive events could be observed in the control capillaries
incubated with the Fc-fragment and in the capillaries coated
with rh P-selectin–Fc-chimera (50 μg/ml) fusion protein (data
not shown).
In order to evaluate themetastatic potential of NB cells in
the presence of BJ, further studies were focused on the effect
of the juice on the SK-N-SH and LAN-1 cell invasiveness. As
shown in Fig. 5, treatment with 0.5, 1 and 5% BJ significantly
reduced the mean number of NB cells able to cross the
Matrigel-coated filter within 24 h. 1% BJ decreased SK-N-SH
and LAN-1 cellmigration up to 50 and 60%, respectively, and 5%
BJ produced decrement of about 70% compared with untreated
cultures in both cell lines (P b 0.001). The anti-invasive effects
of BJ were observed even at a concentration that did not induce
any anti-proliferative or cytotoxic effects (0.5% BJ; −30% in
SK-N-SH and LAN-1 cells; P b 0.01). The migratory capacity of
NB cells in the presence of BJ was evaluated by the wound
healing assay. Pictures of representative wounds after 12 h of
incubation with or without 1% BJ are shown in Fig. 6, in which
the impairment of the cell motility caused by the juice is
appreciable (the wounds appeared to be of the same size as
that of time zero). BJ concentrations higher than 1% increase
weak adherent cells, not allowing a proper analysis of the cell
motility.3.4. Inﬂuence of bergamot juice on primary tumors
and metastasis
Upon subcutaneous injection of SK-N-SH or LAN-1 cells
development of primary tumors was found in 100% of SCID
mice independent of treatment with BJ. Primary tumor weight
varied considerablywithin the groups andwas not significantly
influenced by BJ. However, especially in LAN-1, the number of
disseminated tumor cells in the blood was higher in BJ-treated
mice than in control mice, although this difference was not
statistically significant (P = 0.057; Fig. 7).All control mice with LAN-1 primary tumors produced
pulmonary metastases, with numbers ranging from 5461 to
284785; in the BJ treated group, all mice developed lung
metastases with numbers ranging from 558 to 405058
(Figs. 8 and 9). The number of disseminated LAN-1 tumor
cells in the blood showed a strong positive correlation with
LAN-1 pulmonarymetastases (P b 0.001). In the t-test analysis
the number of lung metastases in BJ-treated LAN-1 SCID mice
exhibited no difference with the control group. However,
including the number of disseminated tumor cells in the blood
as covariate LAN-1 lung metastases were significantly reduced
by BJ treatment (P b 0.01) (Fig. 8C). Nine of ten control mice
with SK-N-SH primary tumors produced pulmonary metasta-
ses (mean: 507); in the BJ-treated group eleven of twelvemice
developed lung metastases (mean: 356). Though the mean of
lung metastases in BJ treated SK-N-SH mice is lower than that
in control mice, t-test analysis did not show a statistically
significant difference.
4. Discussion
Metastasis formation is the spread of tumor cells from a
primary tumor to distant sites in the patient's body. This process
is the end result of a complex series of events depending on the
ability of the tumor cells to detach from the primary tumor, to
migrate and invade connective tissues, to enter into the vascular
or lymphatic system and to achieve vital organs where tumor
cells have to proliferate to form a distant metastasis. The
tendency of a primary tumor to formmetastases is the hallmark
of malignant neoplasms and has important diagnostic, prog-
nostic, and therapeutic implications.
NB is a devastating tumor, already metastatic in 70% of the
patients at the time of diagnosis. NB metastases commonly
affect distant sites including the lungs [24]. Moreover, several
patients develop metastatic disease also after surgical removal
of the primary tumor. Thus, the formation of distantmetastases
is still a major problem in the treatment of NB patients, and
finding novel therapeutic strategies is of great interest in
NB research because of the poor prognosis of children with
disseminated stages. Inhibition of the metastatic potential of
NB cells might prevent disease progression, even for patients
with multiple tumors at diagnosis.
In the present study we demonstrate that BJ significantly
affects SK-N-SH and LAN-1 cell proliferation in vitro, but failed to
reduce primary tumor weight in an in vivo NB xenograft model.
Moreover, we show anti-adhesive and anti-invasive properties
of BJ in vitro and slight anti-metastatic activity in a metastatic
LAN-1 NB xenograft model in vivo. In particular, BJ decreases
LAN-1 lung metastases under consideration of disseminated
tumor cells in the blood. Therefore, through the impairment of
tumor cell adhesive properties BJ may contribute in inhibiting
cancer cell progression.
The influence of BJ in metastasis formation was inves-
tigated in a SCID mouse xenograft model in which lacking
functional B- and T-cells enables the investigation of human
cancer cell metastasis in an entire organism. SK-N-SH and
LAN-1 cells were chosen because of their high tumor take-rate
and a great spontaneous metastatic potential after an accept-
able time period of growth from subcutaneous injection of the
tumor cells [21]. SK-N-SH and LAN-1 cellswere subcutaneously
injected between the scapulae of SCID mice and circulatory
Fig. 2. Effect of BJ on SK-N-SH and LAN-1 cell proliferation. Cells were cultured in the presence of increased concentrations of BJ for 24, 48 and 72 h. Proliferation
rates of SK-N-SH and LAN-1 cells were evaluated by MTT (A) and cell count (B) assays. Results of MTT are expressed as percentage of the values detected in
untreated cells, while data of cell count are presented as the number of live cells counted. Each value is the mean ± SEM of three experiments performed in
eightplicate (MTT test) or in triplicate (cell count). *P b 0.05 vs ctrl; **P b 0.01 vs ctrl; ***P b 0.001 vs ctrl and BJ 0.5%; +P b 0.05 vs BJ 1%; ^P b 0.01 vs BJ 1%;
°P b 0.001 vs BJ 1% (ANOVA, followed by Turkey–Kramer multiple comparison test).
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already described by Nehmann and coworkers [23] we
detected disseminated human tumor cells in small volumes
of the mouse blood with the qRT-PCR for amplifying the
repetitive character of human Alu DNA-sequences. BJ treat-
ment increases the number of human NB cells in the
bloodstream in both cell lines, but this result does not reach
statistical significance. This finding indicates that BJ does notFig. 3. Cytotoxic effects induced by BJ. BJ induces significant cytotoxic effects on
concentration used in this study (10%). Lower concentrations of BJ did not signifi
assessed by the trypan blue test. Data represent mean ± SEM obtained in the thre
followed by Turkey–Kramer multiple comparison test).affect the detachment of NB cells from the primary tumor and
the invasion in a blood vessel, but rather colonization of a
distant site. Of interest, growing deal of experimental data
suggests that progression to intractable fatal metastatic NB
depends not so much on the ability of NB cells to dissociate
from the primary tumor, but on the potential of these cells to
invade distant sites and progress there [25]. Therefore, our
findings appeared highly relevant in the light of several novelSK-N-SH (on the right) and LAN-1 (on the left) cells only at the higher
cantly affect cell viability. Cytotoxicity was evaluated in terms of cell death
e different sets of experiments made in triplicate. *P b 0.05 vs ctrl (ANOVA,
Fig. 4. Results of the laminar flow assay. Adhesion of untreated and 5%
BJ-treated LAN-1 and SK-N-SH cells on rh E-selectin–Fc-chimera (5 μg/ml)
coated microslides. The number of adhesive cells at different shear stresses
(0.5, 1 and 1.5 dyn/cm−2) per time unit and field of view. Data represent
mean ± SEM of the two experiments.
89M. Navarra et al. / Fitoterapia 95 (2014) 83–92anticancer therapies that do not necessarily lead to a tumor
volume or weight reduction [26].
Considering disseminated tumor cells in the blood as
covariate, BJ reduced the number of pulmonary metastases
in LAN-1. Earlier in vivo findings in a colon cancer xenograft
model showed that the knock-out of E- and P-selectins leads
to a decrease of pulmonary metastasis and an increase of
circulating tumor cells as compared to the wild type SCID
mouse [18]. This increase of tumor cells in the bloodstream
is most likely due to the lack of attachment of the tumor cells
to the selectin deficient endothelium at the site of the future
metastasis and the subsequent transmigration of the tumor
cells through the endothelium. However, LAN-1 cells hardly
adhere to selectins in vitro (Fig. 3) indicating that extrava-
sation of LAN-1 cells is independent of selectin expression on
endothelial cells. Probably, these cells make use of other cell
adhesion molecules with regard to extravasation and diapede-
sis, both are requirements for a successfulmetastasis. In this line,
we recently showed that BJ inhibited SH-SY5Y neuroblastoma
cell adhesion on endothelial cell monolayer or other physiologic
substrates [13]. Reduction of both cell adhesiveness and cell
motility involves an impairment of actin filaments, a reduction
in the expression of the active form of focal adhesion kinase
(FAK) and neural cell adhesionmolecule (NCAM), hindering the
association between these two important molecules.Fig. 5. Reduction of NB cell invasiveness by BJ. LAN-1 and SK-N-SH cells treated (fill
filter of Matrigel invasion chambers. Data are reported as percentages of cells count
sets of experiments performed in triplicate. *P b 0.05, **P b 0.01 and ***P b 0.001 vOver the past twenty years, numerous studies have shown
the beneficial properties of flavonoids leading to increased
attention to the Citrus juices which are an important source
of these biomolecules. Their flavonoidic composition may
considerably differ with regard to numerous factors such as
the species, subclass, environmental conditions, crop methods
and harvest time. However, the juice of hand squeezed Citrus
sinensis is characterized by the presence of Hesperidin,Narirutin
and Vicenin-2. Generally, commercial orange juices present
a composition similar to freshly squeezed ones, with some
compounds such as Naringin and Diosmin that indicate the
possibility of a non-pure orange juice. Citrus limon juice is
characterized by the presence of significant amounts of the
flavanones Hesperidin and Eriocitrin. Commercial lemon juices
reflect the composition of the hand-squeezed ones, with the
exception of Hesperidin that often decreases. Among themany
Citrus species the Citrus aurantifolia is the one that is most
commonly referred to as “limes” and its composition closely
resembles the flavonoid content of lemon juice. Citrus paradisi
(grapefruit) juice can generally be found in three different
varieties, red, pink and white, whose color depends on the
presence (or absence) of lycopene. Generally, white grape-
fruit juice is slightly richer in flavonoids than the pink and red
varieties. The main components are the flavanones Naringin
andNaringenin, its aglycone,which has always been recognized
to be a distinctive component of grapefruit juices. Narirutin
is also present in good amounts. C. bergamia hand-squeezed
juice is characterized by the presence of good amounts of the
flavanones Poncirin, Naringin, Neohesperidin andNeoeriocitrin.
Diosmetin 6,8-di-C-glucoside and Apigenin 6,8-di-C-glucoside
are the most abundant flavones, hinting that C. bergamia may
indeed be derived from a hybrid of C. limon and C. sinensis.
Industrial BJ has been found to be extremely rich in flavonoids
amongwhichNeoeriocitrin, Naringin andNeohesperidin are the
most abundant flavanones, whereas Apigenin di-C-glucoside,
and Diosmetin di-C-glucoside are the greater plentiful glycosyl
flavones. Commercial juices tend to be even more concentrated
than their hand-squeezed equivalents, resulting in higher
concentrations of the main components [27]. This very
different flavonoidic composition of the various Citrus juices is
reflected in their heterogeneous biological activity.
Several in vivo studies suggested the potential of Citrus
juices in preventing cancer [7–11], but to our best knowledge,
the scientific literature does not provide evidences on their
anti-metastatic activity. This is the first report suggesting theed bar) or not (empty bar) with BJ 0.25, 0.5, 1 and 5% migrating through the
ed in untreated cultures. Each value represents the mean ± SEM of the three
s respective controls.
Fig. 6. BJ impairs NBmotility. Several wounds were traced in the NB cell monolayer and a photograph was taken (T 0). Then, complete mediumwith or without BJ
1% was added and the migration of cells in the wound was photographed after 12 h. Representative images were taken.
90 M. Navarra et al. / Fitoterapia 95 (2014) 83–92potential of a Citrus juice in reducing metastasis coloniza-
tion. Growing deal of data suggests that Citrus flavonoids
may have inhibitory effects on cancer invasion and migra-
tion, indicating their capability to prevent cancer metastasis.
Nobiletin seems to be the most promising anti-metastatic
molecule because of its ability to suppress intracellular pathways
involved in the metastatic process [28–30]. Apigenin, Quercetin,Fig. 7. Quantification of human tumor cell DNA in the blood of SCID mice. Dissemin
mice (B) were detected by quantification of human Alu DNA-concentrations using qNaringenin and Hesperidin have also shown to reduce invasion
and metastasis of tumor cells through modulation of key
molecules implicated in the processes of metastasis forma-
tion [31]. The peculiarity of our study is that we used a
natural bergamot juice and not juicewith commercial bioactive
molecules, which strengthens the importance to study the
potential anticancer activity of fruits and vegetables by usingated tumor cells (DTCs) in blood (cells/ml) of SK-N-SH- (A) and LAN-1-SCID
RT-PCR. The mean expression levels of all measurements ± SEM are shown.
Fig. 8. Number of spontaneous lung metastases grown in SCID mice. Data, expressed as mean ± SEM, indicate values obtained in BJ-treated and untreated
SK-N-SH (A) and LAN-1 SCID mice (B) group. Considering tumor cells in the blood as covariate, treatment with BJ significantly reduced the number of pulmonary
metastases (C).
91M. Navarra et al. / Fitoterapia 95 (2014) 83–92whole extracts containing all phytochemicals. Indeed, accord-
ing to other researchers, we believe that the complex mixtures
of phytochemicals present in fruits and vegetables could be
more effective than their individual constituents in preventing
cancer through both additive and synergistic effects [32].
This hypothesis is also supported by several case–control
studies documenting the inverse association between Citrus
fruit intake and risk of several types of cancer, including tumor
of the digestive and respiratory tracts, pancreas, prostate, breast,
nasopharynx and cutaneous melanoma [33–37].
In conclusion, this study demonstrates that BJ exerts
significant inhibitory effects on human NB cell proliferation
in vitro and suggests that the slight inhibitory effects on lung
metastasis colonization in vivomay be due to the impairment of
NB cell adhesiveness, migration and invasion observed
in vitro. A lack of any apparent sign of systemic toxicities
suggests a promising role of BJ in oncologic field, demanding
further investigation in cancer and other chronic diseases.
Finally, our findings appear very relevant because the results
shown in this study were obtained using a natural BJ, which
may be converted in a commercial product and used as a
supplement in the healthy field.
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